Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Yesterday, Feb. 12, 2014, 128 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $79.73 to $121,490,730.00.

Highlighted Stocks Traded by Insiders:

Cavium (CAVM) - FREE Research Report

Ali Syed who is Pres., CEO, Chairman of board at Cavium sold 100,000 shares at $38.10 on Feb. 12, 2014. Following this transaction, the Pres., CEO, Chairman of board owned 1.4 million shares meaning that the stake was reduced by 6.8% with the 100,000-share transaction.

The shares most recently traded at $38.32, up $0.22, or 0.57% since the insider transaction. Historical insider transactions for Cavium go as follows:

  • 12-Week # shares sold: 3,000
  • 24-Week # shares sold: 3,000

The average volume for Cavium has been 670,400 shares per day over the past 30 days. Cavium has a market cap of $2.0 billion and is part of the technology sector and electronics industry. Shares are up 10.66% year-to-date as of the close of trading on Wednesday.

Cavium, Inc. designs, develops, and markets semiconductor processors for intelligent and secure networks. Currently there are 10 analysts that rate Cavium a buy, 1 analyst rates it a sell, and 4 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on CAVM - FREE

TheStreet Quant Ratings

rates Cavium as a

hold

. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures and compelling growth in net income. However, as a counter to these strengths, we find that the stock has experienced relatively poor performance when compared with the S&P 500 during the past year. Get the full

Cavium Ratings Report

from

TheStreet Quant Ratings

now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Hologic (HOLX) - FREE Research Report

Macmillan Stephen P who is President and CEO at Hologic bought 38,600 shares at $21.58 on Feb. 12, 2014. Following this transaction, the President and CEO owned 237,500 shares meaning that the stake was reduced by 19.41% with the 38,600-share transaction.

The shares most recently traded at $21.52, down $0.06, or 0.26% since the insider transaction. Historical insider transactions for Hologic go as follows:

  • 4-Week # shares bought: 198,900
  • 4-Week # shares sold: 5,677
  • 12-Week # shares bought: 198,900
  • 12-Week # shares sold: 5,677
  • 24-Week # shares bought: 198,900
  • 24-Week # shares sold: 5,677

The average volume for Hologic has been 3.6 million shares per day over the past 30 days. Hologic has a market cap of $5.9 billion and is part of the health care sector and health services industry. Shares are down 4.21% year-to-date as of the close of trading on Wednesday.

Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women. Currently there are 6 analysts that rate Hologic a buy, 1 analyst rates it a sell, and 12 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on HOLX - FREE

TheStreet Quant Ratings

rates Hologic as a

hold

. Among the primary strengths of the company is its expanding profit margins over time. At the same time, however, we also find weaknesses including deteriorating net income, disappointing return on equity and generally higher debt management risk. Get the full

Hologic Ratings Report

from

TheStreet Quant Ratings

now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Cincinnati Financial Corporation (CINF) - FREE Research Report

Lichtendahl Kenneth C who is Director at Cincinnati Financial Corporation bought 1,050 shares at $45.30 on Feb. 12, 2014. Following this transaction, the Director owned 31,452 shares meaning that the stake was reduced by 3.45% with the 1,050-share transaction.

The shares most recently traded at $46.51, up $1.21, or 2.6% since the insider transaction. Historical insider transactions for Cincinnati Financial Corporation go as follows:

  • 4-Week # shares bought: 3,670
  • 12-Week # shares bought: 3,861
  • 24-Week # shares bought: 4,080

The average volume for Cincinnati Financial Corporation has been 658,100 shares per day over the past 30 days. Cincinnati Financial Corporation has a market cap of $7.6 billion and is part of the financial sector and insurance industry. Shares are down 11.19% year-to-date as of the close of trading on Wednesday.

Cincinnati Financial Corporation engages in the property casualty insurance business in the United States. The stock currently has a dividend yield of 3.8%. The company has a P/E ratio of 14.8. Currently there are no analysts that rate Cincinnati Financial Corporation a buy, no analysts rate it a sell, and 3 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on CINF - FREE

TheStreet Quant Ratings

rates Cincinnati Financial Corporation as a

buy

. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, reasonable valuation levels and notable return on equity. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full

Cincinnati Financial Corporation Ratings Report

from

TheStreet Quant Ratings

now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

null